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Abstract
Perioperative antimicrobial prophylaxis has been a time-honored principle in the prevention of surgical site
infection. Its effectiveness has recently been questioned. Potential reasons for the lack of demonstrable efficacy and
suggestions for re-examination of this concept are presented.
The principles of perioperative antimicrobial prophylaxis
were established more than 40 years ago [1]. This con-
cept has been applied to many areas of surgery and
numerous prospective randomized trials have repeatedly
demonstrated that surgical site infections (SSIs) are
reduced when the right antibiotics are administered
appropriately. This practice has been incorporated into
standardized guidelines for perioperative use through
the Surgical Care Improvement Project (SCIP) and
serves as a major process measurement for appropriate-
ness of practice [2]. First and second generation cepha-
losporins have been the major drug class recommended
and used for prophylaxis for decades and there has been
little change in these recommendations over time.
Recent reports have demonstrated a lack of correlation
between the use of guideline-directed perioperative anti-
microbial prophylaxis, that is, administration of the right
drug at the right time for the right duration and its pri-
mary outcome measure, prevention of SSI [3,4]. This
begs the question: could we have been wrong about the
benefits of perioperative antimicrobial prophylaxis?
There are a number of potential explanations for these
observations. This principle has been so widely accepted
that some propose that all patients receive antimicrobial
prophylaxis regardless of the operation and risk of infec-
tion [5]. This concept fails to consider the risk: benefit
r a t i oo fe v e ns i n g l ed o s ed r u gu s e ,s i n c et h e r ei sas m a l l
but defined risk of allergic and other adverse reactions
associated with most antibiotics. Overuse blurs the
advantage of prophylaxis, as many who wouldn’t benefit
would still receive prophylaxis and supports the concept
of unrelated attribution. This is exemplified as “if you
want to show the benefit of a drug, give it to those who
don’t need it; it works every time.” Although it is recog-
nized that perioperative prophylaxis is not the only pre-
ventive measure for SSI, failure to apply other measures
such as appropriate skin cleansing, scrubbing of operat-
ing room personnel, use of aseptic technique, mechani-
cal bowel preparation, and avoidance of undo
contamination subjects patients to complications and
can negate the beneficial effects of prophylaxis. In addi-
tion, the increasing prevalence of minimally invasive
surgical procedures, which are associated with a lower
r i s ko fS S It h a no p e no p e r a tions for the same condi-
tions, may also be impacting these observations [6].
We now understand that there are patient characteris-
tics that also affect the risk of infection and can negate
the beneficial effects of antimicrobial prophylaxis. These
include glycemic control, tissue dessication, hypother-
mia, obesity, smoking, immunosuppressive drugs, nutri-
tional state, and local tissue hypoxemia. Addressing each
of these contributors requires a well-coordinated, team-
based approach in order to consistently optimize the
strategy to prevent SSI.
In spite of the complexity of this problem, there are
other questions about perioperative prophylaxis that
have not been adequately addressed. For instance, three
of the most common pathogens for SSIs- Staphylococcus
aureus, coagulase-negative staphylococci, and entero-
cocci- are frequently resistant to currently recom-
mended agents. Should we expect that prophylaxis that
is not demonstrable in vitro will work in our patients?
Patients frequently report a history of allergic reaction
to beta-lactam drugs and as a result, secondary agents
are used. The data for selection of these agents are
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class 2 evidence [7]. Is it possible that our assumptions
about their effectiveness are wrong? We know that the
prevention of SSI also depends on delivery of an effec-
tive concentration of antibiotic to the site at risk for
infection, in this case the surgical incision. With cepha-
losporins, tissue concentrations are often dependent on
weight-based dosing and so adjustments need to be
made for overweight and obese patients [8]. Do we
know the compliance with this principle?
There has been much progress made in surgery over
the four decades since the benefits of perioperative anti-
microbial prophylaxis were demonstrated in a prospec-
tive, randomized clinical trial. We now understand more
about the complex interactions that affect SSI. We need
to look to the challenges ahead and consider whether
new principles need to be formulated.
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